HealthDay (10/31, Preidt) reports, “Many pregnant women may wonder if antidepressants – or other drugs acting on the brain’s neurotransmitters – might raise their” infants’ “odds of developing autism.” A new study “suggests that’s not the case.” However, “a mother’s health before and during pregnancy may play a role in autism spectrum disorders,” researchers concluded after evaluating “the risks associated with 180 medications that target neurotransmitters, including antidepressants and antipsychotics,” using “data from nearly 100,000 children born in Israel between 1997 and 2007.” The findings were published online Oct. 31 in JAMA Psychiatry.
According to MedPage Today (10/31, George), the authors of an accompanying editorial wrote, “It would be hasty to conclude that specific drug classes have no associations with autism because there may be other mechanisms at play.” The editorialists added, “Further, it is important to recognize that a full profile of the pharmacological properties of many of the drugs examined in this study is still unknown.” Healio (10/31, Demko) also covers the study.
Related Links:
— “Autism Risk: Mom’s Health May Matter More Than Meds, ” Robert Preidt, HealthDay, October 31, 2018.